Beijing Tong Ren Tang Chinese Medicine Company Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BJTRF research report →
Companywww.tongrentangcm.com
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services.
- CEO
- Wang Chi
- IPO
- 2021
- Employees
- 782
- HQ
- Wan Chai, HK
Price Chart
Valuation
- Market Cap
- $542.78M
- P/E
- 13.08
- P/S
- 3.70
- P/B
- 1.43
- EV/EBITDA
- 7.07
- Div Yield
- 4.91%
Profitability
- Gross Margin
- 62.14%
- Op Margin
- 32.76%
- Net Margin
- 28.32%
- ROE
- 11.18%
- ROIC
- 9.77%
Growth & Income
- Revenue
- $1.51B · -6.12%
- Net Income
- $397.12M · 516.89%
- EPS
- $0.47 · -21.67%
- Op Income
- $473.47M
- FCF YoY
- 417.51%
Performance & Tape
- 52W High
- $0.65
- 52W Low
- $0.65
- 50D MA
- $0.65
- 200D MA
- $0.65
- Beta
- 0.40
- Avg Volume
- 185.6
Get TickerSpark's AI analysis on BJTRF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BJTRF Coverage
We haven't published any research on BJTRF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BJTRF Report →